Dermatology · White Oak, PA
NPI
1811998875
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1220 Lincoln Way, Suite 101
White Oak, PA, 15131
Phone (412) 678-8806
Groups this clinician bills Medicare through
Medicare paid, 2024
$118K
10,301 services
Medicare patients, 2024
573
Average age 74
Drug cost, 2024
$1.4M
2,076 prescriptions
Company payments, 2025
$4,211
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lawrence M Stokar was code J7345 (aminolevulinic acid hcl for topical administration, 10% gel, 10 mg), 8,600 times for 41 patients. In total Lawrence M Stokar billed 10,301 services in 77 codes, and Medicare paid $118K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-18.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 8,600 | 41 | $1.30 | $11K |
| 99213 Office E&M - Established | Office | 436 | 366 | $58.11 | $25K |
| 17003 Destruction Skin Lesion | Office | 389 | 104 | $4.64 | $1,805 |
| 17000 Destruction Skin Lesion | Office | 162 | 137 | $40.91 | $6,628 |
| 99203 Office E&M - New | Office | 76 | 76 | $51.90 | $3,945 |
| 99214 Office E&M - Established | Office | 68 | 48 | $83.20 | $5,657 |
| 11301 Removal or Shaving of Skin Growth | Office | 44 | 33 | $69.05 | $3,038 |
| 96574 Skin | Office | 42 | 40 | $161.86 | $6,798 |
| 13132 Wound Repair - All Levels | Office | 29 | 24 | $300.47 | $8,714 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 28 | 21 | $0.75 | $20.89 |
| 11310 Removal or Shaving of Skin Growth | Office | 28 | 21 | $48.29 | $1,352 |
| 11900 Skin | Office | 26 | 21 | $38.32 | $996 |
| 99212 Office E&M - Established | Office | 25 | 25 | $39.49 | $987 |
| 11300 Removal or Shaving of Skin Growth | Office | 23 | 16 | $32.34 | $744 |
| 11311 Removal or Shaving of Skin Growth | Office | 22 | 22 | $82.30 | $1,811 |
By year: 2022 $116K for 4,659 services; 2023 $126K for 9,438 services; 2024 $118K for 10,301 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lawrence M Stokar prescribed most often to Medicare patients was Triamcinolone Acetonide, with 317 prescriptions and refills. In total Lawrence M Stokar wrote 2,076 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 317 | 326 | 198 | $2,982 |
| Ketoconazole Generic | 250 | 259 | 122 | $4,002 |
| Hydrocortisone Generic | 240 | 255 | 166 | $3,048 |
| Betamethasone Dipropionate Generic | 116 | 122 | 73 | $4,566 |
| Prednisone Generic | 110 | 142 | 70 | $261 |
| Finasteride Generic | 96 | 144 | 16 | $613 |
| Mupirocin Generic | 95 | 97 | 68 | $501 |
| Doxycycline Hyclate Generic | 95 | 114 | 46 | $1,265 |
| Clobetasol Propionate Generic | 94 | 96 | 60 | $3,951 |
| Terbinafine Hcl Generic | 89 | 90 | 40 | $643 |
| Cephalexin Generic | 74 | 74 | 65 | $920 |
| Otezla Apremilast | 37 | 37 | Under 11 | $177K |
| Hydroxyzine Hcl Generic | 36 | 38 | 13 | $497 |
| Methotrexate Methotrexate Sodium | 36 | 51 | Under 11 | $254 |
| Clindamycin Phosphate Generic | 36 | 36 | 26 | $1,011 |
Brand drugs: 164 claims; generic drugs: 1,912 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lawrence M Stokar $4,211 ($4,211 in general payments such as food, travel and fees) from 22 companies. The largest payer was Abbvie Inc. with $790.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 30 | $790 |
| UCB, Inc. UCB.BR | 26 | $571 |
| LEO Pharma Inc. | 30 | $509 |
| Janssen Biotech, Inc. JNJ | 20 | $340 |
| Journey Medical Corporation DERM | 5 | $293 |
| Pfizer Inc. PFE | 14 | $285 |
| Amgen Inc. AMGN | 16 | $230 |
| Galderma Laboratories, L.P. GALD.SW | 23 | $228 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $203 |
| Incyte Corporation INCY | 7 | $163 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.